☰

Gennaro Pagano - Publications

Affiliations: 
Cardiology UNiversità degli Studi di Napoli Federico II 
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Brundin P, Svoboda H, Bonni A, Pagano G. This is NOT the End for Immunotherapy in Parkinson's Disease - A Perspective from Early Drug Development Scientists. Journal of Parkinson's Disease. PMID 36404558 DOI: 10.3233/JPD-229008  0.355
2022 Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Azulay JP, Mollenhauer B, López-Manzanares L, Russell DS, Boyd JT, Nicholas AP, et al. Trial of Prasinezumab in Early-Stage Parkinson's Disease. The New England Journal of Medicine. 387: 421-432. PMID 35921451 DOI: 10.1056/NEJMoa2202867  0.397
2022 Lipsmeier F, Taylor KI, Postuma RB, Volkova-Volkmar E, Kilchenmann T, Mollenhauer B, Bamdadian A, Popp WL, Cheng WY, Zhang YP, Wolf D, Schjodt-Eriksen J, Boulay A, Svoboda H, Zago W, ... Pagano G, et al. Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson's disease. Scientific Reports. 12: 12081. PMID 35840753 DOI: 10.1038/s41598-022-15874-4  0.49
2022 Wilson H, Pagano G, Yousaf T, Polychronis S, De Micco R, Giordano B, Niccolini F, Politis M. Correction to: Predict cognitive decline with clinical markers in Parkinson's disease (PRECODE-1). Journal of Neural Transmission (Vienna, Austria : 1996). PMID 35230538 DOI: 10.1007/s00702-022-02476-7  0.341
2021 Pagano G, Boess FG, Taylor KI, Ricci B, Mollenhauer B, Poewe W, Boulay A, Anzures-Cabrera J, Vogt A, Marchesi M, Post A, Nikolcheva T, Kinney GG, Zago WM, Ness DK, et al. A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data. Frontiers in Neurology. 12: 705407. PMID 34659081 DOI: 10.3389/fneur.2021.705407  0.48
2021 Kremer T, Taylor KI, Siebourg-Polster J, Gerken T, Staempfli A, Czech C, Dukart J, Galasko D, Foroud T, Chahine LM, Coffey CS, Simuni T, Weintraub D, Seibyl J, Poston KL, ... ... Pagano G, et al. Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33942926 DOI: 10.1002/mds.28608  0.468
2021 Ahamadi M, Mehrotra N, Hanan N, Yee KL, Gheyas F, Anton J, Bani M, Boroojerdi B, Smit H, Weidemann J, Macha S, Thuillier V, Chen C, Yang M, Williams-Gray CH, ... ... Pagano G, et al. A disease progression model to quantify the non-motor symptoms of Parkinson's disease in participants with leucine-rich repeat kinase 2 mutation. Clinical Pharmacology and Therapeutics. PMID 33894056 DOI: 10.1002/cpt.2277  0.464
2020 Wilson H, Pagano G, de Natale ER, Mansur A, Caminiti SP, Polychronis S, Middleton LT, Price G, Schmidt KF, Gunn RN, Rabiner EA, Politis M. Mitochondrial Complex 1, Sigma 1, and Synaptic Vesicle 2A in Early Drug-Naive Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32347983 DOI: 10.1002/mds.28064  0.355
2019 Wilson H, Pagano G, Yousaf T, Polychronis S, De Micco R, Giordano B, Niccolini F, Politis M. Predict cognitive decline with clinical markers in Parkinson's disease (PRECODE-1). Journal of Neural Transmission (Vienna, Austria : 1996). PMID 31853652 DOI: 10.1007/s00702-019-02125-6  0.344
2019 Niccolini F, Wilson H, Giordano B, Diamantopoulos K, Pagano G, Chaudhuri KR, Politis M. Sleep disturbances and gastrointestinal dysfunction are associated with thalamic atrophy in Parkinson's disease. Bmc Neuroscience. 20: 55. PMID 31640554 DOI: 10.1186/s12868-019-0537-1  0.539
2019 Wilson H, Dervenoulas G, Pagano G, Tyacke RJ, Polychronis S, Myers J, Gunn RN, Rabiner EA, Nutt D, Politis M. Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson's disease: an in vivo11C-BU99008 PET study. Brain : a Journal of Neurology. PMID 31504212 DOI: 10.1093/Brain/Awz260  0.377
2019 Wilson H, Dervenoulas G, Pagano G, Koros C, Yousaf T, Picillo M, Polychronis S, Simitsi A, Giordano B, Chappell Z, Corcoran B, Stamelou M, Gunn RN, Pellecchia MT, Rabiner EA, et al. Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study. The Lancet. Neurology. PMID 31229470 DOI: 10.1016/S1474-4422(19)30140-1  0.432
2019 Pagano G, Niccolini F, Wilson H, Yousaf T, Khan NL, Martino D, Plisson C, Gunn RN, Rabiner EA, Piccini P, Foltynie T, Politis M. Comparison of phosphodiesterase 10A and dopamine transporter levels as markers of disease burden in early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31158314 DOI: 10.1002/Mds.27733  0.436
2019 Maghzi H, Hogg EJ, Tan E, Pagano G, Tagliati M. Adrenoceptor agonists and antagonists and risk of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 34: 442. PMID 30875150 DOI: 10.1002/mds.27611  0.506
2019 Wilson H, Pagano G, Niccolini F, Muhlert N, Mehta MA, Searle G, Gunn RN, Rabiner EA, Foltynie T, Politis M. The role of phosphodiesterase 4 in excessive daytime sleepiness in Parkinson's disease. Parkinsonism & Related Disorders. PMID 30824285 DOI: 10.1016/j.parkreldis.2019.02.027  0.478
2018 de Natale ER, Wilson H, Pagano G, Politis M. Imaging Transplantation in Movement Disorders. International Review of Neurobiology. 143: 213-263. PMID 30473196 DOI: 10.1016/bs.irn.2018.10.002  0.308
2018 Pagano G, De Micco R, Yousaf T, Wilson H, Chandra A, Politis M. REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease. Neurology. PMID 30089615 DOI: 10.1212/WNL.0000000000006134  0.502
2018 Schulz J, Pagano G, Fernández Bonfante JA, Wilson H, Politis M. Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease. Brain : a Journal of Neurology. 141: 1501-1516. PMID 29701787 DOI: 10.1093/brain/awy072  0.335
2018 Pagano G, Polychronis S, Wilson H, Giordano B, Ferrara N, Niccolini F, Politis M. Diabetes mellitus and Parkinson disease. Neurology. PMID 29626177 DOI: 10.1212/WNL.0000000000005475  0.327
2017 Niccolini F, Wilson H, Pagano G, Coello C, Mehta MA, Searle GE, Gunn RN, Rabiner EA, Foltynie T, Politis M. Loss of phosphodiesterase 4 in Parkinson disease: Relevance to cognitive deficits. Neurology. PMID 28701494 DOI: 10.1212/WNL.0000000000004201  0.477
2017 Pagano G, Niccolini F, Yousaf T, Wilson H, Polychronis S, Chaudhuri KR, Politis M. Urinary dysfunction in early de novo patients with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28256013 DOI: 10.1002/mds.26967  0.437
2016 Pagano G, Niccolini F, Fusar-Poli P, Politis M. Serotonin transporter in Parkinson's disease: A meta-analysis of PET studies. Annals of Neurology. PMID 28019672 DOI: 10.1002/Ana.24859  0.482
2016 Pagano G, Molloy S, Bain PG, Rabiner EA, Chaudhuri KR, Brooks DJ, Pavese N. Sleep problems and hypothalamic dopamine D3 receptor availability in Parkinson disease. Neurology. PMID 27807182 DOI: 10.1212/Wnl.0000000000003396  0.349
2016 Roy R, Niccolini F, Pagano G, Politis M. Cholinergic imaging in dementia spectrum disorders. European Journal of Nuclear Medicine and Molecular Imaging. PMID 26984612 DOI: 10.1007/s00259-016-3349-x  0.395
2016 Pagano G, Ferrara N, Brooks DJ, Pavese N. Age at onset and Parkinson disease phenotype. Neurology. 86: 1400-7. PMID 26865518 DOI: 10.1212/Wnl.0000000000002461  0.519
2016 Taylor S, Gafton J, Shah B, Pagano G, Chaudhuri KR, Brooks DJ, Pavese N. Progression of nonmotor symptoms in subgroups of patients with non-dopamine-deficient Parkinsonism. Movement Disorders : Official Journal of the Movement Disorder Society. 31: 344-51. PMID 26863920 DOI: 10.1002/Mds.26456  0.509
2015 Qamhawi Z, Towey D, Shah B, Pagano G, Seibyl J, Marek K, Borghammer P, Brooks DJ, Pavese N. Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease. Brain. 138: 2964-2973. PMID 26209314 DOI: 10.1093/Brain/Awv215  0.305
2015 Pagano G, Tan EE, Haider JM, Bautista A, Tagliati M. Constipation is reduced by beta-blockers and increased by dopaminergic medications in Parkinson's disease. Parkinsonism & Related Disorders. 21: 120-5. PMID 25483722 DOI: 10.1016/j.parkreldis.2014.11.015  0.545
2015 Pagano G, Rengo G, Pasqualetti G, Femminella GD, Monzani F, Ferrara N, Tagliati M. Cholinesterase inhibitors for Parkinson's disease: a systematic review and meta-analysis. Journal of Neurology, Neurosurgery, and Psychiatry. 86: 767-73. PMID 25224676 DOI: 10.1136/jnnp-2014-308764  0.558
Show low-probability matches.